| Literature DB >> 18416811 |
André L J Ferraz1, Ana Ojeda, Manel López-Béjar, Lana T Fernandes, Anna Castelló, Josep M Folch, Miguel Pérez-Enciso.
Abstract
BACKGROUND: Artificial selection has resulted in animal breeds with extreme phenotypes. As an organism is made up of many different tissues and organs, each with its own genetic programme, it is pertinent to ask: How relevant is tissue in terms of total transcriptome variability? Which are the genes most distinctly expressed between tissues? Does breed or sex equally affect the transcriptome across tissues?Entities:
Mesh:
Year: 2008 PMID: 18416811 PMCID: PMC2335121 DOI: 10.1186/1471-2164-9-173
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1NJ (left) and UPGMA trees (right) using the 1 - . Each sample is named using the tissue acronym (four letters, Table 1), breed (LW or IB) and sex (M, male or F, female); LW males are indicated by open squares; LW females, by open circles; IB males, by black squares and IB females, by black circles.
Figure 2NJ tree of tissues using the 1-. The four groups in Table 1 are indicated by symbols: brain (open squares), endocrine (grey squares), structural (grey triangles) and metabolic (black circles).
Tissues sampled
| Brain | Olfactory bulb | OLFB | Ectoderm (neural) | Perception of odors | Whole organ from both sides | 274 | Neuroactive ligand-receptor interaction WNT signalling pathway |
| Hypothalamus | HYPT | Ectoderm (neural) | Regulates metabolic processes and other activities of the Autonomic Nervous System | Including mammilary body and grey tubercle | 147 | Neuroactive ligand-receptor interaction Cell adhesion molecules (CAMS) | |
| Pineal gland | PING | Ectoderm (neural) | Production of melatonin | Whole gland | 89 | - | |
| Adenohypophysis | AHYP | Ectoderm (stomodeum) | Hormone secretion regulating endocrine glands | Whole gland | 241 | Neuroactive ligand-receptor interaction | |
| Neurohypophysis | NHYP | Ectoderm (neural) | Store and liberation of hormones synthesized by the hypothalamus | Whole gland | 130 | WNT signalling pathway | |
| Endocrine | Adrenal cortex | ADGC | Mesoderm | Synthesis of corticosteroid hormones | Part of the gland after mechanical separation | 14 | - |
| Adrenal medulla | ADGM | Ectoderm (Neural crest) | Synthesis of adrenaline and noradrenalin | Part of the gland after mechanical separation | 12 | - | |
| Thyroid gland | THYG | Endoderm + Ectoderm (neural crest) | Production of thyroxine (T4), triiodothyronine (T3), and calcitonin | Part of the gland | 376 | - | |
| Structural | Diaphragm muscle | DIAP | Mesoderm | Predominant oxidative metabolism | Samples from left and right crura | 166 | Oxidative phosphorylation ATP synthesis Glycolysis Citrate cycle Piruvate metabolism |
| BIFE | Mesoderm | Glycolitic metabolism | Lateral area of the muscle | 354 | Glycolysis Insulin signalling pathway Frutose and manose metabolism Starch and sucrose metabolism Pentose phosphate pathway | ||
| Back fat tissue | FATB | Mesoderm | Fat | Fat from lumbar region | 51 | - | |
| Abdominal fat tissue | FATA | Mesoderm | Fat | Fat external to the rectus sheath | 21 | - | |
| Metabolic | Stomach | STOM | Endoderm | Digestion | Epithelium from the body | 156 | Tight junction |
| Liver | LIVR | Endoderm | Central role in metabolism | Parts from quadrate and left lateral lobes | 824 | Urea cycle Bile acid biosynthesis Biosynthesis of steroids Complement and coagulation cascades Fatty acid metabolism Propanoate metabolism Amino acids metabolisms Butanoate metabolism Metabolism of xenobiotics by cytochrome P450 | |
| Ileum | ILEU | Endoderm | Absorption of products of digestion | Epithelium | 570 | Cell cycle Ribosome Pyrimidine metabolism Antigen processing and presentation | |
| Blood | BLOO | Mesoderm | Supply of oxygen and nutrients | Blood from the femoral vein | 3253 | Hematopoietic cell lineage Regulation of actin cytoskeleton T-cell receptor signalling Focal adhesion ECM receptor interaction Cytokine cytokine receptor interaction Cell adhesion molecules (CAMS) MAPK signalling pathway JAK-STAT signalling pathway Tight junction |
a The complete list is in Supplementary Table S2. See Material and Methods for definition of extreme probe.
Figure 3Differential GO categories across embryo layers. Percentage of the most frequent GO categories within extreme genes for each embryonic layer (A, ectoderm; B, mesoderm; C, endoderm; D, all genes in A, B and C). The number in each category is the false discovery rate (FDR) that the category is over represented with respect to the GO frequency across all genes in the microarray. The FDR is shown only if < 0.20.
Parameter estimates
| Complete | 0.87 | - | - | - | |
| Complete | 0.86 | 0.11 | - | - | |
| Complete | 0.85 | - | 0.01 | - | |
| Complete | 0.85 | - | - | 0.01 | |
| 100 largest zb | 0.46 | - | 0.25 | - | |
| 100 largest zs | 0.25 | - | - | 0.48 |
Differentially expressed genes between sexes at FDR < 0.05
| Gene | Symbol | Probe | Function, GO-process | |
| DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked | DDX3Y | Ssc.7473.1.A1_at | 20.96 | Nucleoside-triphosphatase activity |
| Eukaryotic translation initiation factor 2, subunit 3 gamma, | EIF2S3 | Ssc.16426.1.S1_at | 20.19 | Protein metabolism/translation regulator activity |
| FAM5C – family with sequence similarity 5, member C | FAM5C | Ssc.6667.1.A1_at | -18.80 | Unknown |
| Eukaryotic translation initiation factor 1A, Y-linked | EIF1AY | Ssc.26799.1.S1_at | 18.77 | Translational initiation/translation regulator activity |
| DENN/MADD domain containing 4A | DENND4A | Ssc.13426.1.A1_at | -18.07 | Regulation of transcription, DNA-dependent |
| Protein tyrosine phosphatase, receptor type, M | PTPRM | Ssc.31029.1.A1_at | -16.39 | Protein amino acid dephosphorylation/protein tyrosine phosphatase activity |
| Latrophilin 2 | LPHN2 | Ssc.21512.1.A1_at | -15.40 | Neuropeptide signaling pathway/signal transducer activity |
| Homeodomain interacting protein kinase 2 | HIPK2 | Ssc.2434.1.A1_at | -14.25 | Positive regulation of programmed cell death/transcription regulator activity |
| Circadian locomoter output cycles kaput; clock homolog | CLOCK | Ssc.4897.1.A1_at | -14.10 | Circadian rhythm/transcription regulator activity |
| Thymosin, beta 4, X-linked | TMSB4X | Ssc.27304.1.S1_at | 12.26 | Cytoskeleton organization and biogenesis/actin binding |
| Ubiquitously transcribed tetratricopeptide repeat gene, Y-linked | UTY | Ssc.27236.1.S1_at | 11.10 | Unknown. Positive regulation of growth rate ( |
| Jumonji, AT rich interactive domain 1C | JARID1C | Ssc.21814.1.S1_at | 8.41 | Regulation of transcription, DNA-dependent/oxidoreductase activity |
| Ubiquitously transcribed tetratricopeptide repeat, X chromosome | UTX | Ssc.15821.1.S1_at | 7.45 | Unknown. Positive regulation of growth rate ( |
| Glutathione S-transferase A1 | GSTA1 | Ssc.16377.1.A1_at | 6.67 | Glutathione metabolism/transferase activity |
| Major histocompatibility complex, class I, A | HLA-A | Ssc.13780.11.S1_x_at | 4.81 | Antigen processing, endogenous antigen via MHC class I/MHC class I receptor activity |
| Major histocompatibility complex, class I, B | HLA-B | Ssc.18552.1.S1_at | 4.39 | Antigen processing, endogenous antigen via MHC class I/MHC class I receptor activity |
| Major histocompatibility complex, class I, B | HLA-B | Ssc.18554.1.S1_x_at | -4.38 | Antigen processing, endogenous antigen via MHC class I/ |
| Zinc finger protein, X-linked | ZFX | Ssc.26228.1.S1_at | 4.19 | Regulation of transcription/transcriptional activator activity |
| Hypothetical protein FLJ20035 | Q8IY21 | Ssc.18924.1.A1_at | -3.95 | Unknown |
z – scores correspond to male minus female contrasts.
Differentially expressed genes between breeds at FDR < 0.05
| Gene | Symbol | Probe | z-score | Function, GO-process |
| Prostaglandin E synthase 2 | PTGS2 | Ssc.25850.1.A1_at | 10.20 | Regulation of inflammatory response/prostaglandin-endoperoxide synthase activity |
| Hypothetical protein DKFZp313A2432 | Q8NHG7 | Ssc.29609.2.A1_at | - 9.11 | Unknown |
| ATPase, H+ transporting, lysosomal 31 kDa, V1 subunit E1 | ATP6V1G2 | Ssc.12005.1.A1_at | 8.97 | Purine ribonucleotide metabolism/ion transporter activity |
| Synovial sarcoma, X breakpoint 2 interacting protein | SSX2IP | Ssc.28283.1.A1_at | 8.89 | Cell adhesion |
| Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A | SEMA3A | Ssc.29388.1.A1_at | 7.74 | Cell differentiation (nervous system development) |
| DIDO1 death inducer-obliterator 1 | DATF1 | Ssc.14412.1.A1_at | 7.46 | Apoptosis ( |
| Hypothetical protein DKFZp313A2432 | Q8NHG7 | Ssc.29609.1.S1_at | - 7.18 | Unknown |
| Immunoglobulin heavy constant mu | IGHM | Ssc.7706.1.A1_at | 7.09 | Response to biotic stimulus/signal transducer activity |
| Major histocompatibility complex, class I, B | HLA-B | Ssc.18554.1.S1_x_at | - 6.61 | Antigen processing, endogenous antigen via MHC class I/MHC class I receptor activity |
| Armadillo repeat containing, X-linked 1 | ARMCX1 | Ssc.5616.1.S1_at | - 6.42 | Cellular component |
| Tousled-like kinase 2 | TLK2 | Ssc.30422.1.A1_at | 6.36 | Establishment and/or maintenance of chromatin architecture/transferase activity, transferring phosphorus-containing groups |
| Follistatin-like 4 | FSTL4 | Ssc.11743.1.S1_at | - 6.15 | Calcium ion binding |
| Hypothetical protein | Q8N5E3 | Ssc.1256.1.A1_at | - 6.03 | Unknwon |
| Transcription factor CP2 | TFCP2 | Ssc.7954.1.A1_at | - 5.83 | Regulation of nucleic acid metabolism/transcription regulator activity |
| Major histocompatibility complex, class I, A | HLA-A | Ssc.13780.11.S1_x_at | - 5.60 | Antigen processing, endogenous antigen via MHC class I/MHC class I receptor activity |
| Golgi phosphoprotein 4 | GOLPH4 | Ssc.25176.1.A1_at | - 5.12 | Cellular component |
| Enoyl Coenzyme A hydratase domain containing 1 | ECHDC1 | Ssc.1146.1.S1_at | 4.86 | Metabolism/catalytic activity |
| Glycoprotein M6B | GPM6B | Ssc.8133.1.A1_at | 4.85 | Cell differentiation (nervous system development)/molecular function unknown |
| Hypothetical protein | C21orf88 | Ssc.22421.1.A1_at | - 4.68 | Unknwon |
| Polo-like kinase 2 | PLK2 | Ssc.29934.1.A1_at | - 4.67 | Positive regulation of signal transduction/transferase activity, transferring phosphorus-containing groups |
| Hypothetical protein | Q9NV98 | Ssc.5839.2.A1_at | - 4.67 | Unknwon |
| Lysozyme | LYZ | Ssc.670.1.S1_at | - 4.58 | Cellular catabolism (cell death)/hydrolase activity, acting on glycosyl bonds |
| RAB18, member RAS oncogene family | RAB18 | Ssc.30567.1.A1_at | - 4.56 | Endocytosis/pyrophosphatase activity |
| Zinc finger protein 12 | ZNF12 | Ssc.10665.1.A1_at | - 4.56 | Regulation of cellular process/zinc ion binding |
| Splicing factor, arginine/serine-rich 2, interacting protein | SFRS2IP | Ssc.12708.1.A1_at | - 4.50 | mRNA processing |
| Immunoglobulin heavy constant mu | IGHM | Ssc.11070.1.S1_at | - 4.46 | Response to biotic stimulus/signal transducer activity |
| Synapsin III | SYN3 | Ssc.3880.1.S1_at | -4.43 | Regulation of neurotransmitter levels (transmission of nerve impulse)/purine nucleotide binding |
| Deleted in liver cancer 1 | DLC1 | Ssc.18150.1.A1_at | - 4.40 | Negative regulation of growth/enzyme regulator activity |
| DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | DDX17 | Ssc.8674.1.A1_at | 4.24 | Nucleobase, nucleoside, nucleotide and nucleic acid metabolism/nucleoside-triphosphatase activity |
| Potassium channel modulatory factor 1 | KCMF1 | Ssc.25963.1.A1_at | 4.16 | Channel or pore class transporter activity |
| Mitochondrial carrier homolog 2 | MTCH2 | Ssc.6054.2.S1_at | - 4.12 | Transport |
| Cytoskeleton-associated protein 4 | CKAP4 | Ssc.2147.2.A1_at | 4.09 | Cellular component |
| Blood vessel epicardial substance | BVES | Ssc.15540.1.A1_at | - 3.82 | Muscle development |
z – scores correspond to Large White minus Iberian contrasts.
Figure 4Relation between . Plot of z-scores of breeds and sexes (top), and between the breed z-scores and the standard deviation within probes of Probe × Tissue solutions (bottom).
Figure 5Sample clustering using differentially expressed genes. Genes differentially expressed between sexes (top) and breeds (bottom).
QRT-PCR results for CLOCK gene, probe Ssc.4897.1.A1_at
| 13 | F | Duroc | 1.000 | NA |
| 14 | F | Duroc | 1.555 | NA |
| 16 | F | Duroc | 2.694 | NA |
| 22 | F | Iberian | 1.114 | NA |
| 25 | F | Iberian | 2.054 | NA |
| 26 | F | Iberian | 1.581 | NA |
| 8 | F | Landrace | 1.621 | NA |
| 10 | F | Landrace | 1.521 | NA |
| 1 | F | Large White | 1.272 | NA |
| 3 | F | Large White | 1.796 | NA |
| 5 | F | Large White | 2.696 | NA |
| 6 | F | Large White | 1.961 | NA |
| 17 | F | Synthetic | 1.951 | NA |
| 21 | F | Synthetic | 3.482 | NA |
| 12 | M | Duroc | BLD | BLD |
| 15 | M | Duroc | BLD | BLD |
| 23 | M | Iberian | BLD | BLD |
| 24 | M | Iberian | BLD | 0.012 |
| 27 | M | Iberian | BLD | 0.010 |
| 7 | M | Landrace | BLD | BLD |
| 9 | M | Landrace | BLD | BLD |
| 11 | M | Landrace | BLD | 0.001 |
| 2 | M | Large White | BLD | 0.003 |
| 4 | M | Large White | BLD | BLD |
| 18 | M | Synthetic | BLD | BLD |
| 19 | M | Synthetic | BLD | BLD |
| 20 | M | Synthetic | BLD | BLD |
Sex: F, female; M, male
RQ (1/2000): Relative quantification RQ, average of three replicates each, at 1/2000 cDNA dilution. The results are given in terms of sample number 13, used as calibrator, i.e., RQ = 1
RQ (1/20): Relative quantification RQ, average of three replicates each, at 1/20 cDNA dilution, only analyzed for males
BLD, below limit of detection
NA, not available
Correlation between between z-scores in different tissue groups
| All | Brain | Endocrine | Structural | Metabolic | |
| All | - | 0.98 | 0.97 | 0.98 | 0.97 |
| Brain | 0.79 | - | 0.92 | 0.96 | 0.91 |
| Endocrine | 0.87 | 0.62 | - | 0.92 | 0.97 |
| Structural | 0.83 | 0.46 | 0.68 | - | 0.93 |
| Metabolic | 0.77 | 0.34 | 0.63 | 0.64 | - |
The tissues included in each group are listed in Table 1. The z-scores correspond to the 100 largest differentially expressed genes when all tissues are jointly analyzed. Upper diagonal, sex differentially expressed genes. Lower diagonal, breed differentially expressed genes.
Figure 6Proportion of functional annotation categories. Percentage of the most frequent GO categories within the most significant differentially expressed genes between sexes (Table 3) and between breeds (Table 4). The number in each category is the false discovery rate (FDR) that the category is over represented with respect to the GO frequency across all genes in the microarray. The FDR is shown only if < 0.20.